UB Paderborn / Katalog / Suche / in CDI

Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

The FEBS journal, 2012-04, Vol.279 (8), p.1386-1397

2012

Link zum Volltext

Verfügbarkeit prüfen

Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring

The European journal of neuroscience, 2014-05, Vol.39 (10), p.1558-1571

2014

Link zum Volltext

Verfügbarkeit prüfen

Prenatal inhibition of the tryptophan–kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus

Brain research, 2013-04, Vol.1504, p.1-15

2013

Link zum Volltext

Verfügbarkeit prüfen

Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway

Brain research, 2014-08, Vol.1576, p.1-17

2014

Link zum Volltext

Verfügbarkeit prüfen

Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring

Molecular brain, 2012-06, Vol.5 (1), p.22-22, Article 22

2012

Link zum Volltext

Verfügbarkeit prüfen

Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+/− mice, using liquid chromatography-tandem mass spectrometry

Neurochemistry international, 2016-11, Vol.100, p.110-119

2016

Link zum Volltext

Verfügbarkeit prüfen

On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio

International journal of tryptophan research, 2010-01, Vol.2010 (3), p.51-59

2010

Link zum Volltext

Verfügbarkeit prüfen

Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation

Immunopharmacology and immunotoxicology, 2013-10, Vol.35 (5), p.581-593

2013

Link zum Volltext

Verfügbarkeit prüfen

Dependence receptor involvement in subtilisin-induced long-term depression and in long-term potentiation

Neuroscience, 2016-11, Vol.336, p.49-62

2016

Link zum Volltext

Verfügbarkeit prüfen

Quinolinic acid induces neuritogenesis in SH‐SY5Y neuroblastoma cells independently of NMDA receptor activation

The European journal of neuroscience, 2017-03, Vol.45 (5), p.700-711

2017

Link zum Volltext

Verfügbarkeit prüfen

Serine protease modulation of Dependence Receptors and EMT protein expression

Cancer biology & therapy, 2019-03, Vol.20 (3), p.349-367

2019

Link zum Volltext

Verfügbarkeit prüfen

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

Journal of neurochemistry, 2010, Vol.112 (1), p.112-122

2010

Link zum Volltext

Verfügbarkeit prüfen

Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery

Journal of neurochemistry, 2011-10, Vol.119 (1), p.136-152

2011

Link zum Volltext

Verfügbarkeit prüfen

Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

Journal of Neural Transmission, 2012-02, Vol.119 (2), p.261-274

2012

Link zum Volltext

Verfügbarkeit prüfen

Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer

BMC cancer, 2016-10, Vol.16 (1), p.772-772, Article 772

2016

Link zum Volltext

Verfügbarkeit prüfen

Kynurenine Pathway Activation in Human African Trypanosomiasis

The Journal of infectious diseases, 2017-03, Vol.215 (5), p.806-812

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin

British journal of clinical pharmacology, 2007-10, Vol.64 (4), p.517-526

2007

Link zum Volltext

Verfügbarkeit prüfen

KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING

Clinical and experimental pharmacology & physiology, 2009-04, Vol.36 (4), p.425-435

2009

Link zum Volltext

Verfügbarkeit prüfen

KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENT

Clinical and experimental pharmacology & physiology, 2006-11, Vol.33 (11), p.1078-1087

2006

Link zum Volltext

Verfügbarkeit prüfen

Tryptophan Metabolites and Brain Disorders

Clinical chemistry and laboratory medicine, 2003-07, Vol.41 (7), p.852-859

2003

Link zum Volltext

Verfügbarkeit prüfen

Molecular changes associated with hippocampal long-lasting depression induced by the serine protease subtilisin-A

The European journal of neuroscience, 2011-10, Vol.34 (8), p.1241-1253

2011

Link zum Volltext

Verfügbarkeit prüfen

Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease

Advances in experimental medicine and biology, 2003, Vol.527, p.395

2003

Link zum Volltext

Verfügbarkeit prüfen

Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment

Advances in experimental medicine and biology, 2003, Vol.527, p.287

2003

Link zum Volltext

Verfügbarkeit prüfen

Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease

Journal of biomedical science, 2002-09, Vol.9 (5), p.436-442

2002

Link zum Volltext

Verfügbarkeit prüfen

Quinolinic acid induces neuritogenesis in SH ‐ SY 5Y neuroblastoma cells independently of NMDA receptor activation

The European journal of neuroscience, 2017-03, Vol.45 (5), p.700-711

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring

Prenatal inhibition of the tryptophan–kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus

Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway

Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring

Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+/− mice, using liquid chromatography-tandem mass spectrometry

On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio

Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation

Dependence receptor involvement in subtilisin-induced long-term depression and in long-term potentiation

Quinolinic acid induces neuritogenesis in SH‐SY5Y neuroblastoma cells independently of NMDA receptor activation

Serine protease modulation of Dependence Receptors and EMT protein expression

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery

Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer

Kynurenine Pathway Activation in Human African Trypanosomiasis

Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin

KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING

KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENT

Tryptophan Metabolites and Brain Disorders

Molecular changes associated with hippocampal long-lasting depression induced by the serine protease subtilisin-A

Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease

Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment

Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease

Quinolinic acid induces neuritogenesis in SH ‐ SY 5Y neuroblastoma cells independently of NMDA receptor activation

Suchergebnisse filtern